BCM
LOACR

Basso Capital Management’s Longevity Acquisition Corporation Right LOACR Stock Holding History

Basso Capital Management’s Portfolio LOACR Stock Details LOACR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-105,664
Closed -$24K – 291
2020
Q3 		$24K Hold
105,664
– – 0.01% 164
2020
Q2 		$21K Buy
+105,664
New +$16.3K 0.01% 175

Other funds holding LOACR

OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Basso Capital Management's LOACR Position: Q4 2020 in Review

Basso Capital Management sold out of Longevity Acquisition Corporation Right (LOACR) in Q4 2020, closing a stake of 105,664 shares — an estimated $24K sold.

Basso Capital Management first reported a position in LOACR in Q2 2020 and held it in 2 quarters. The position peaked at $24K in Q3 2020. 7 funds tracked by Wall St. Rank hold LOACR as of Q4 2020.

  • Basso Capital Management reported no remaining Longevity Acquisition Corporation Right position as of Q4 2020 after selling out during the quarter.
  • Basso Capital Management sold 105,664 Longevity Acquisition Corporation Right shares in Q4 2020, an estimated $24K.
  • Basso Capital Management first reported a position in Longevity Acquisition Corporation Right in Q2 2020 and held it in 2 quarters.
  • Basso Capital Management's Longevity Acquisition Corporation Right position peaked at $24K in Q3 2020.
  • 7 funds tracked by Wall St. Rank held Longevity Acquisition Corporation Right as of Q4 2020.

Based on Basso Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.